f) Aspirin

Yes

This is the most widely used platelet inhibitor and no other anti-platelet agent has a more impressive risk-benefit and cost-benefit ratio. Aspirin works by blocking cyclooxygenase, which converts arachidonic acid to prostaglandins, which will later be converted to thromboxane A2. In patients admitted for unstable angina there can be as much as a 51% reduction in fatal and nonfatal MI (7).

There may be more than one correct answer for this decision point.